Keymed’s Stapokibart approved by NMPA for seasonal allergic rhinitis
China's National Medical Products Administration (NMPA) has approved Keymed Biosciences’ supplemental new drug application (NDA) for Stapokibart to treat seasonal …
Post
-
-
Fourth person receives eGenesis’ gene-edited pig kidney transplant
A 66-year-old man has become the fourth person in the world to receive a genetically edited pig kidney transplant, performed …
-
Super Bowl ad for copycat weight loss drugs stokes pharma power debate
As the Philadelphia Eagles romped to victory against the Kansas City Chiefs in the Super Bowl LIX, the eyes of …
-
Eton secures US patent for diabetes insipidus treatment
Eton Pharmaceuticals has secured a patent from the US Patent and Trademark Office (USPTO) for its ET-600 product candidate’s desmopressin …
-
FDA approves AbbVie’s Emblaveo for intra-abdominal infections
AbbVie has received US Food and Drug Administration (FDA) approval for Emblaveo (aztreonam and avibactam) to be used in conjunction …
-
Bain Capital buys Mitsubishi Tanabe Pharma for $3.3bn
US private equity firm Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit Mitsubishi Tanabe Pharma in a …
-
Impact of proposed US tariffs on pharmaceutical FDI in Canada, Mexico, China and Europe
The pharmaceutical industry is bracing for potentially major disruptions following US President Donald Trump’s announcement of new tariffs on imported …
-
Sanofi increases ownership stake partaking in pharma buyback trend
Just days after taking back some of the stake held by L’Oréal, Sanofi has agreed to repurchase its own shares …
-
Alumis and Acelyrin sign merger agreement
Alumis and Acelyrin have announced a definitive merger agreement, which will result in an all-stock transaction, creating a late-stage clinical …
-
43rd Annual JP Morgan Healthcare Conference 2025 OR
The 43rd Annual JP Morgan Healthcare Conference took place in San Francisco, California on January 13–16, 2025. This annual conference is …
-
Genentech eyes lupus market for Gazyva with positive Phase III data readout
Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company …
-
How AI is streamlining cell and gene therapy manufacturing
AI has frequently been in the headlines recently due to its potentially transformative capabilities — and the technology is making …
-
Relmada acquires Tourette’s therapy rights from Asarina
Relmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma. Sepranolone is a neurosteroid being …
-
Treating alcohol addiction: filling the medication gap
With Dry January firmly behind us, many adults are prompted to reassess their relationship with alcohol. Alcohol Change, the UK …
-
Dr Reddy’s and Shanghai Henlius sign agreement for HLX15
Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15, a daratumumab biosimilar …
